Skip to main content

Table 2 Independent predictors of survival from a multivariate Cox proportional hazards model at the first and second rounds of TACE

From: Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Variables

At the first TACE

At the second TACE

HR (95% CI)

P value

HR (95% CI)

P value

Male gender

1.09 (0.86–1.38)

0.501

Tumor size (cm)

 

< 0.001

 

< 0.001

 ≤7

1

 

1

 

 >7

1.90 (1.53–2.36)

 

1.91 (1.36–2.69)

 

Tumor number

 

< 0.001

 

< 0.001

 Unifocal

1

 

1

 

 Multifocal

1.73 (1.43–2.09)

 

1.78 (1.45–2.19)

 

Alpha-fetoprotein (ng/mL)

 

< 0.001

 

< 0.001

 ≤400

1

 

1

 

 >400

1.58 (1.27–1.95)

 

2.31 (1.63–3.28)

 

Total bilirubin (mg/dL)

 

0.006

 

0.241

 ≤0.9

1

 

1

 

 >0.9

1.31 (1.08–1.58)

 

1.14 (0.91–1.43)

 

Serum albumin (g/dL)

 

< 0.001

 

0.004

 ≥3.6

1

 

1

 

 <3.6

1.45 (1.19–1.77)

 

1.39 (1.11–1.75)

 
  1. TACE; transarterial chemoembolization; HR, hazard ratio; CI, confidence interval